IMRX Stock Up on FDA's Orphan Drug Tag for Pancreatic Cancer Drug

Zacks Oct 16 09:35 ET

12 Health Care Stocks Moving In Tuesday's Intraday Session

BenzingaOct 15 12:32 ET

Immuneering Says Potential Pancreatic Cancer Treatment Gets FDA Orphan Drug Designation

MT NewswiresOct 15 09:16 ET

Notable Labs NTBL Chapter 7 Bankruptcy; Immuneering IMRX Orphan Drug Designation

BioPharmCatalystOct 15 09:06 ET

Immuneering Granted Orphan Drug Designation for IMM-1-104

TipRanksOct 15 08:21 ET

Express News | Immuneering Corp: Imm-1-104 Is Currently Being Evaluated in a Phase 2a Clinical Trial

ReutersOct 15 08:03 ET